Literature DB >> 10202203

The autonomic nervous system in functional bowel disorders.

G Tougas1.   

Abstract

Communications along the brain-gut axis involve neural pathways as well as immune and endocrine mechanisms. The two branches of the autonomic nervous system are integrated anatomically and functionally with visceral sensory pathways, and are responsible for the homeostatic regulation of gut function. The autonomic nervous system is also a major mediator of the visceral response to central influences such as psychological stress. As defined, functional disorders comprise a constellation of symptoms, some of which suggest the presence of altered perception, while other symptoms point to disordered gastrointestinal function as the cause of the symptoms. A growing number of reports have demonstrated disordered autonomic function in subgroups of functional bowel patients. While a number of different methods were used to assess autonomic function, the reports point to a generally decreased vagal (parasympathetic) outflow or increased sympathetic activity in conditions usually associated with slow or decreased gastrointestinal motility, while other studies found either an increased cholinergic activity or a decreased sympathetic activity in patients with symptoms compatible with an increased motor activity. Under certain conditions, altered autonomic balance (including low vagal tone and increased sympathetic activity) may alter visceral perception. Autonomic dysfunction may also represent the physiological pathway accounting for many of the extraintestinal symptoms seen in irritable bowel syndrome patients and some of the frequent gastrointestinal complaints reported by patients with disorders such as chronic fatigue and fibromyalgia.

Entities:  

Mesh:

Year:  1999        PMID: 10202203     DOI: 10.1155/1999/707105

Source DB:  PubMed          Journal:  Can J Gastroenterol        ISSN: 0835-7900            Impact factor:   3.522


  13 in total

1.  Autonomic activity and somatic symptoms in response to success vs. failure on a cognitive task: a comparison of chronic abdominal pain patients and well children.

Authors:  Martina Puzanovova; Patrick G Arbogast; Craig A Smith; Julia Anderson; André Diedrich; Lynn S Walker
Journal:  J Psychosom Res       Date:  2009-04-15       Impact factor: 3.006

Review 2.  Irritable bowel syndrome.

Authors:  S M Turner; J E Stewart; J J Alexopulos; J S Hill
Journal:  Curr Rev Pain       Date:  2000

3.  Distinct subclassification of DRG neurons innervating the distal colon and glans penis/distal urethra based on the electrophysiological current signature.

Authors:  Kristofer K Rau; Jeffrey C Petruska; Brian Y Cooper; Richard D Johnson
Journal:  J Neurophysiol       Date:  2014-05-28       Impact factor: 2.714

4.  Sympathetic hyperactivity in patients with ulcerative colitis.

Authors:  Simona Maule; Giulia Pierangeli; Sabina Cevoli; Daniela Grimaldi; Paolo Gionchetti; Giovanni Barbara; Fernando Rizzello; Vincenzo Stanghellini; Roberto Corinaldesi; Massimo Campieri; Pietro Cortelli
Journal:  Clin Auton Res       Date:  2007-06-15       Impact factor: 4.435

Review 5.  Chronic functional bowel syndrome enhances gut-brain axis dysfunction, neuroinflammation, cognitive impairment, and vulnerability to dementia.

Authors:  Mak Adam Daulatzai
Journal:  Neurochem Res       Date:  2014-03-04       Impact factor: 3.996

Review 6.  Cognitive behavioral approach to understanding irritable bowel syndrome.

Authors:  Goran Hauser; Sanda Pletikosic; Mladenka Tkalcic
Journal:  World J Gastroenterol       Date:  2014-06-14       Impact factor: 5.742

7.  Evidence for autonomic dysregulation in the irritable bowel syndrome.

Authors:  Vishal Gupta; David Sheffield; G Nicholas Verne
Journal:  Dig Dis Sci       Date:  2002-08       Impact factor: 3.199

8.  Baroreflex mechanisms in Irritable Bowel Syndrome: Part I. Traditional indices.

Authors:  Dmitry M Davydov; Bruce Naliboff; Leila Shahabi; David Shapiro
Journal:  Physiol Behav       Date:  2016-02-02

Review 9.  Efficacy of the low FODMAP diet for treating irritable bowel syndrome: the evidence to date.

Authors:  Wathsala S Nanayakkara; Paula Ml Skidmore; Leigh O'Brien; Tim J Wilkinson; Richard B Gearry
Journal:  Clin Exp Gastroenterol       Date:  2016-06-17

10.  Risk for irritable bowel syndrome in fibromyalgia patients: a national database study.

Authors:  Tse-Yen Yang; Chih-Sheng Chen; Cheng-Li Lin; Wei-Ming Lin; Chua-Nan Kuo; Chia-Hung Kao
Journal:  Medicine (Baltimore)       Date:  2015-03       Impact factor: 1.889

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.